Literature DB >> 31426681

Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.

Hamiyet Donmez-Altuntas1,2, Fahri Bayram3, Ayse N Coskun-Demirkalp1,4, Osman Baspınar5, Derya Kocer6, Peter P Toth7,8.   

Abstract

Entities:  

Keywords:  8-hydroxy-2′-deoxyguanosine levels; DNA damage; Dyslipidemia; cytokinesis-block micronucleus cytome assay; micronucleus; statin therapy

Mesh：

Substances：

Year:  2019        PMID： 31426681      PMCID： PMC6775566          DOI： 10.1177/1535370219871895

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  39 in total

1.  Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly.

Authors:  Fahri Bayram; Nazmiye Bitgen; Hamiyet Donmez-Altuntas; Ilkay Cakir; Zuhal Hamurcu; Fatma Sahin; Yasin Simsek; Gulden Baskol
Journal:  Growth Horm IGF Res       Date:  2013-12-14       Impact factor: 2.372

2.  Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells.

Authors:  Michihiro Kamigaki; Tamito Sasaki; Masahiro Serikawa; Motoki Inoue; Kenso Kobayashi; Hiroshi Itsuki; Tomoyuki Minami; Masanobu Yukutake; Akihito Okazaki; Takashi Ishigaki; Yasutaka Ishii; Keiichi Kosaka; Kazuaki Chayama
Journal:  Int J Oncol       Date:  2011-06-17       Impact factor: 5.650

3.  In vitro protective effect of atorvastatin against ionizing radiation induced genotoxicity in human lymphocytes.

Authors:  S J Hosseinimehr; M Izakmehri; A Ghasemi
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2015-03-28       Impact factor: 1.770

4.  Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients.

Authors:  T Inoue; K Inoue; H Maeda; K Takayanagi; S Morooka
Journal:  Clin Chim Acta       Date:  2001-03       Impact factor: 3.786

5.  Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.

Authors:  C Denoyelle; M Vasse; M Körner; Z Mishal; F Ganné; J P Vannier; J Soria; C Soria
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

6.  Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease.

Authors:  Maria Grazia Andreassi; Nicoletta Botto; Silvana Simi; Marta Casella; Samantha Manfredi; Marilena Lucarelli; Lucia Venneri; Andrea Biagini; Eugenio Picano
Journal:  J Mol Med (Berl)       Date:  2005-03-16       Impact factor: 4.599

Review 7.  Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death.

Authors:  Michael Fenech
Journal:  Mutat Res       Date:  2006-07-05       Impact factor: 2.433

Review 8.  The in vitro micronucleus technique.

Authors:  M Fenech
Journal:  Mutat Res       Date:  2000-11-20       Impact factor: 2.433

9.  The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

Authors:  Randa A El-Zein; Mirtha S Lopez; Anthony M D'Amelio; Mei Liu; Reginald F Munden; David Christiani; Li Su; Paula Tejera-Alveraz; Rihong Zhai; Margaret R Spitz; Carol J Etzel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-29       Impact factor: 4.254

10.  The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia.

Authors:  V Ciaravino; M L Kropko; C E Rothwell; C A Hovey; J C Theiss
Journal:  Mutat Res       Date:  1995-06       Impact factor: 2.433
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.